A new study indicates that cholesterol-lowering statin drugs may be associated with a 15% lower risk of developing dementia in patients.
Researchers are investigating the specific biological mechanisms by which statins potentially benefit brain health, noting that the timing of administration appears to be a critical factor.
The findings are particularly relevant for diabetic patients, as many are already prescribed statins to manage heart health, potentially offering a secondary protective benefit against cognitive decline.